The Effects of Butyrate on Induced Metabolic-Associated Fatty Liver Disease in Precision-Cut Liver Slices

Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (steatosis) and can progress to more severe stages such as non-alcoholic steatohepatitis (NASH) and even cirrhosis. Butyrate, and butyrate-producing bacteria, have been suggested to reduce liver steatosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Prins, Grietje H., Rios-Morales, Melany, Gerding, Albert, Reijngoud, Dirk-Jan, Olinga, Peter, Bakker, Barbara M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703944/
https://www.ncbi.nlm.nih.gov/pubmed/34959755
http://dx.doi.org/10.3390/nu13124203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703944/
https://www.ncbi.nlm.nih.gov/pubmed/34959755
http://dx.doi.org/10.3390/nu13124203

Ejemplares similares